These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2684345)

  • 1. Pretreatment with the NMDA antagonist dextrorphan reduces cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; Saleh J; DeLaPaz R; Kunis D; Zarnegar SR
    Brain Res; 1989 Sep; 497(2):382-6. PubMed ID: 2684345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits.
    Steinberg GK; Saleh J; Kunis D; DeLaPaz R; Zarnegar SR
    Stroke; 1989 Sep; 20(9):1247-52. PubMed ID: 2672427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection after transient focal cerebral ischemia by the N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels.
    Steinberg GK; Kunis D; Saleh J; DeLaPaz R
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):1015-24. PubMed ID: 1939379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed treatment with dextromethorphan and dextrorphan reduces cerebral damage after transient focal ischemia.
    Steinberg GK; Saleh J; Kunis D
    Neurosci Lett; 1988 Jun; 89(2):193-7. PubMed ID: 3292967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan alters cerebral blood flow and protects against cerebral injury following focal ischemia.
    Steinberg GK; Lo EH; Kunis DM; Grant GA; Poljak A; DeLaPaz R
    Neurosci Lett; 1991 Dec; 133(2):225-8. PubMed ID: 1816501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextromethorphan protects against cerebral injury following transient focal ischemia in rabbits.
    Steinberg GK; George CP; DeLaPaz R; Shibata DK; Gross T
    Stroke; 1988 Sep; 19(9):1112-8. PubMed ID: 3413809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dextrorphan and levorphanol selectively block N-methyl-D-aspartate receptor-mediated neurotoxicity on cortical neurons.
    Choi DW; Peters S; Viseskul V
    J Pharmacol Exp Ther; 1987 Aug; 242(2):713-20. PubMed ID: 3039122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan reduces neocortical ischemic neuronal damage in vivo.
    George CP; Goldberg MP; Choi DW; Steinberg GK
    Brain Res; 1988 Feb; 440(2):375-9. PubMed ID: 3359222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotection by N-methyl-D-aspartate antagonists in focal cerebral ischemia is dependent on continued maintenance dosing.
    Steinberg GK; Yoon EJ; Kunis DM; Sun GH; Maier CM; Grant GA
    Neuroscience; 1995 Jan; 64(1):99-107. PubMed ID: 7708219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depression of N-methyl-D-aspartate-mediated responses by dextrorphan in the hippocampal slice in rat.
    Cole AE; Eccles CU; Aryanpur JJ; Fisher RS
    Neuropharmacology; 1989 Mar; 28(3):249-54. PubMed ID: 2657479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traumatic neuronal injury in vitro is attenuated by NMDA antagonists.
    Tecoma ES; Monyer H; Goldberg MP; Choi DW
    Neuron; 1989 Jun; 2(6):1541-5. PubMed ID: 2576374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile.
    Steinberg GK; Kunis D; DeLaPaz R; Poljak A
    Neurol Res; 1993 Jun; 15(3):174-80. PubMed ID: 8103583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dextrorphan and dextromethorphan, common antitussives, are antiepileptic and antagonize N-methyl-D-aspartate in brain slices.
    Wong BY; Coulter DA; Choi DW; Prince DA
    Neurosci Lett; 1988 Feb; 85(2):261-6. PubMed ID: 2897648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrow temporal therapeutic window for NMDA antagonist protection against focal cerebral ischaemia.
    Steinberg GK; Panahian N; Pérez-Pinzón MA; Sun GH; Modi MW; Sepinwall J
    Neurobiol Dis; 1995 Apr; 2(2):109-18. PubMed ID: 8980014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive neuroprotective effects of dextrorphan and cycloheximide in rats subjected to transient focal cerebral ischemia.
    Du C; Hu R; Csernansky CA; Liu XZ; Hsu CY; Choi DW
    Brain Res; 1996 Apr; 718(1-2):233-6. PubMed ID: 8773794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextrorphan and dextromethorphan attenuate glutamate neurotoxicity.
    Choi DW
    Brain Res; 1987 Feb; 403(2):333-6. PubMed ID: 2881608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury.
    Du C; Hu R; Hsu CY; Choi DW
    J Neurotrauma; 1996 Apr; 13(4):215-22. PubMed ID: 8860202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
    Dawson DA; Graham DI; McCulloch J; Macrae IM
    Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against focal cerebral ischemia following exposure to a pulsed electromagnetic field.
    Grant G; Cadossi R; Steinberg G
    Bioelectromagnetics; 1994; 15(3):205-16. PubMed ID: 8074737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibition of plasma kallikrein protects brain from reperfusion injury.
    Storini C; Bergamaschini L; Gesuete R; Rossi E; Maiocchi D; De Simoni MG
    J Pharmacol Exp Ther; 2006 Aug; 318(2):849-54. PubMed ID: 16705080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.